About CELLEPUS THERAPEUTICS, INC.
Cellepus Therapeutics is a biotechnology company focused on developing off-the-shelf, 'turbocharged' γδ1/3 CAR-T cells for the treatment of solid tumors. Their platform utilizes precision engineering, scalable manufacturing, and novel antigen targets to create a state-of-the-art cell therapy.
Is this your company?
Claim CELLEPUS THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim CELLEPUS THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.